Isolated Vitreoretinal Amyloidosis in the Absence of Transthyretin Mutations

Archives of Ophthalmology

Volumn 122, Issue 1, 2004, Pages 123-125

  Barouch, Fina C ^a   Benson, Merrill D ^a   Mukai, Shizuo ^a,b  

^a Massachusetts Eye and Ear Infirmary ^*

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PREALBUMIN;

AGED; AMYLOIDOSIS; ARTICLE; CASE REPORT; DNA SEQUENCE; FEMALE; GENE MUTATION; GERIATRIC PATIENT; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; VISUAL ACUITY; VITREORETINOPATHY; VITREOUS BIOPSY;

AGED; AMYLOIDOSIS; EYE DISEASES; FEMALE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; PREALBUMIN; RETINAL DISEASES; VITRECTOMY; VITREOUS BODY;

EID: 0346093906     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.1.123     Document Type: Article

References (6)

1. Bhisitkul RB, Mukai S. Vitreous amyloidosis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmotogy. 2nd ed. Philadelphia, Pa: WB Saunders Co; 2000:2530-2539.
2. Kantarian AD, De Jong RN. Familial primary amyloidosis with nervous system involvement. Neurology. 1953;3:399-409.
3. Westermark P, Sletten K, Johansson B, Cornwell GG III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A. 1990;87:2843-2845.
4. Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002;346: 1786-1791.
5. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms of vitreous involvement. Surv Ophthalmol. 1995;40:173-196.
6. Schwartz MF, Green WR, Michels RM, Kincaid MC, Fogle J. An unusual case of ocular involvement in primary systemic nonfamilial amyloidosis. Ophthalmology. 1982;89:394-401.